Prologue Medicines Revenue and Competitors

USA

Location

N/A

Total Funding

Biotech

Industry

Employee Data

  • Prologue Medicines has 27 Employees.(i)
  • Prologue Medicines grew their employee count by 93% last year.

Prologue Medicines's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$10.1M655%N/AN/A
#10
$16.1M1049%N/AN/A
Add Company

What Is Prologue Medicines?

Prologue is designing powerful new medicines by unlocking the viral proteome. The company’s state-of-the-art DELVE™ Platform systematically identifies and evaluates viral proteins and their unique features for their potential to precisely regulate human physiology. By co-opting viral evolution, Prologue is expanding the functional boundaries of proteins encoded by the human genome to create new programmable medicines. Prologue was founded by Flagship Pioneering in 2021.

keywords:N/A

N/A

Total Funding

27

Number of Employees

N/A

Revenue (est)

93%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.2M27-7%N/A
#2
$4.6M270%N/A
#3
$2.8M2717%$11.6M
#4
$2.5M27-32%N/A
#5
$4.6M27-10%N/A